DI
RGNX icon

DAGCO Inc’s Regenxbio RGNX Stock Holding History

DAGCO Inc’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-191
Closed -$3.43K – 353
2023
Q4 		$3.43K Buy
+191
New +$3.36K ﹤0.01% 232

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

DAGCO Inc's RGNX Position: Q1 2024 in Review

DAGCO Inc sold out of Regenxbio (RGNX) in Q1 2024, closing a stake of 191 shares — an estimated $3.43K sold.

DAGCO Inc first reported a position in RGNX in Q4 2023 and held it in 1 quarter. The position peaked at $3.43K in Q4 2023. 188 funds tracked by Wall St. Rank hold RGNX as of Q1 2024.

  • DAGCO Inc reported no remaining Regenxbio position as of Q1 2024 after selling out during the quarter.
  • DAGCO Inc sold 191 Regenxbio shares in Q1 2024, an estimated $3.43K.
  • DAGCO Inc first reported a position in Regenxbio in Q4 2023 and held it in 1 quarter.
  • DAGCO Inc's Regenxbio position peaked at $3.43K in Q4 2023.
  • 188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2024.

Based on DAGCO Inc's 13F filing for Q1 2024, filed 15 May 2024.